Fundz

Avs Raises $20 Million In Series B Round To Advance Pulsatile Intravascular Lithotripsy (Pivl) Solutions

PRIVATEJan 05, 2023

Amount Raised

$20 Million

Round Type

Series B

BostonManufacturing

Investors

Bio Star Capital

Description

AVS, an early-stage medical device company focused on safely and effectively treating severely calcified arterial disease with its PIVLTM therapy, announced today that it raised $20 million in Series B financing. The new funding will accelerate clinical trial timelines for the company’s device for peripheral application in pulsatile intravascular lithotripsy (PIVL) cases and advance development and preclinical work on a PIVL device for coronary cases.

Quick answer

Amplitude Vascular Systems raised $20 Million in a Series B round, dated January 5, 2023. Investors: Bio Star Capital. Amplitude Vascular Systems is based in Boston, Massachusetts, United States.

How much did Amplitude Vascular Systems raise?
Amplitude Vascular Systems raised $20 Million in a Series B round on January 5, 2023.
Who invested in Amplitude Vascular Systems?
Bio Star Capital is named as investors in this round.
What does Amplitude Vascular Systems do?
AVS is an early-stage medical device company focused on safely and effectively treating severely calcified arterial disease.
Where is Amplitude Vascular Systems based and how big is it?
Amplitude Vascular Systems is based in Boston, Massachusetts, United States. Fundz records about 10 employees.
Who are the decision-makers at Amplitude Vascular Systems?
Fundz holds 1 contact at Amplitude Vascular Systems. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Manufacturing around the same time

Companies in the same sectors as Amplitude Vascular Systems that raised within 45 days of this round, from Fundz verified event records.

  • Rubi Laboratories raised $13M on February 16, 2023.
  • Zyus raised $19K (Pre-Seed) on February 16, 2023.
  • Three Chord Bourbon raised an undisclosed amount (Series A) on February 16, 2023.
  • Pudu Robotics raised $15M (Series C) on February 16, 2023.
  • CardioMech AS raised $4.5M (Seed) on February 16, 2023.
  • Quantum Brilliance raised $18M (Funding Round) on February 15, 2023.

Who to call at Amplitude Vascular Systems, and when

A new round usually means Amplitude Vascular Systems is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Amplitude Vascular Systems raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Amplitude Vascular Systems, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Amplitude Vascular Systems. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Amplitude Vascular Systems

Location

451 D St

Boston, Massachusetts, United States

About

AVS is an early-stage medical device company focused on safely and effectively treating severely calcified arterial disease. It was founded in 2018 by Hitinder Gurm, M.D., Interventional Cardiologist and Chief Clinical Officer at University of Michigan, and Robert Chisena, Ph.D., Chief Technical Officer at AVS. We are redefining interventional therapy for severely calcified lesions with our Pulse IVL System, which uses a novel pulsatile mechanism of action to shatter calcium and expand narrowed vessels, all with a single device.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Amplitude Vascular Systems raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Amplitude Vascular Systems's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

Amplitude Vascular Systems raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.